The Journal of
Clinical Psychiatry

Volume 66 • 2005 • 1

Brainstorms

Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder?

J Clin Psychiatry 2005;66(1):5-6

Stephen M. Stahl, MD, PhD

Original Research

Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity

J Clin Psychiatry 2005;66(1):7-14

Kevin L. Sloan, MD; Molly M. Shores, MD; Victoria M. Moceri, PhD; Alvin M. Matsumoto, MD; Daniel R. Kivlahan, PhD

Original Research

The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation

J Clin Psychiatry 2005;66(1):15-27

Jose de Leon, MD; Margaret T. Susce, RN, MLT; Run-Mei Pan, BSc; Maureen Fairchild, PhD; Walter H. Koch, PhD; Peter J. Wedlund, PhD

Original Research

Sertraline Treatment of Pathological Gambling: A Pilot Study

J Clin Psychiatry 2005;66(1):28-33

Carlos Blanco, MD, PhD; Angela Ibáñez, MD, PhD; Xavier Masramon, BSc; Margarita M. Gómez, MD; María Madrigal, MD; Teresa DÃez, MD

Original Research

Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder

J Clin Psychiatry 2005;66(1):34-40

Daniel B. Burnham, PhD; David V. Sheehan, MD, MBA; Philip Perera, MD; Malini K. Iyengar, PhD

Original Research

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

J Clin Psychiatry 2005;66(1):41-48

Charles B. Nemeroff, MD, PhD; Charles L. Raison, MD; Andrey S. Borisov, MD, MPH; Sherry D. Broadwell, PhD; Lucile Capuron, PhD; Bobbi J. Woolwine, MSW; Ira M. Jacobson, MD; Andrew H. Miller, MD

Original Research

The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients

J Clin Psychiatry 2005;66(1):49-51

Kathryn M. Connor, MD; Victoria M. Payne, MD; Kishore M. Gadde, MD; Wei Zhang, MD, PhD; Jonathan R. T. Davidson, MD

Original Research

Assessing the Utility of Atypical Antipsychotic Medication in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders

J Clin Psychiatry 2005;66(1):52-62

John Hennen, PhD; Karen J. Shedlack, MD; Christine Magee, MS; Daniel M. Cheron, BA

Original Research

A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine: Efficacy and Safety

J Clin Psychiatry 2005;66(1):63-72

Herbert Y. Meltzer; A. Elif Anil Yağcıoğlu, MD; Berna B Kivircik Akdede, MD; Tolga İ. Turgut, MD; Mevhibe Tümüklü, MD; M. Kâzim Yazici, MD; Köksal Alptekin, MS; Aygün Ertugrul, MD; Karu Jayathilake, MS; Ahmet Gögüs, MD; Zeliha Tunca, MD

Original Research

Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study

J Clin Psychiatry 2005;66(1):73-79

Lorrin M. Koran, MD; Alexander Bystritsky, MD; Tanya Vapnik, PhD, RN; Helen W. Chuong, MS; Ann M. Bogan, MD

Original Research

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

J Clin Psychiatry 2005;66(1):80-84

Robert R. Conley, MD; Deanna L. Kelly, PharmD, BCPP

Original Research

A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

J Clin Psychiatry 2005;66(1):85-93

Maurizio Fava, MD; Michael E. Thase, MD; Charles DeBattista, MD

Original Research

Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety Disorder: A Double-Blind, Prospective Comparison Between Paroxetine and Sertraline

J Clin Psychiatry 2005;66(1):94-99

Andrew W. Goddard, MD; Susan G. Ball, PhD; Angela Kuhn, MA; Delynda Wall, MS; Anathat Shekhar, MD, PhD

Original Research

Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine

J Clin Psychiatry 2005;66(1):100-106

Michael E. Thase, MD; Mikael Landén, MD, PhD; Per Högberg, BSc

Original Research

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

J Clin Psychiatry 2005;66(1):107-110

Joseph Bergman, MD; Tzvi Dwolatzky, MD; Izidor Brettholz, MD; Vladimir Lerner, MD, PhD

Original Research

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

J Clin Psychiatry 2005;66(1):111-121

Charles L. Bowden, MD; Heinz Grunze, MD; Martin Brecher, MD; Björn Paulsson, MD; Jamie Mullen, MD; Martin Jones, Msc; Mårten Vågerö, PhL; K. Svensson, MSc

Academic Highlights

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

J Clin Psychiatry 2005;66(1):122-123

Rajiv Tandon, MD; Peter J. Weiden, M.D.; John M. Kane, M.D.; Henry A. Nasrallah, MD; Anissa Abi-Dargham, MD

Letter to the Editor

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

J Clin Psychiatry 2005;66(1):134

Jambur Ananth, MD

Letter to the Editor

Interactions of Cyclobenzaprine and Tricyclic Antidepressants

J Clin Psychiatry 2005;66(1):134-135

Nicholas Z. Rosenlicht, MD; Kristin P. Riley-Lazo, MD

Letter to the Editor

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

J Clin Psychiatry 2005;66(1):135-136

Ronald Pies, MD; S. Tziporah Cohen, MD; Daphne Rulf, MD

Letter to the Editor

Problems in Assessing Musical Hallucinations

J Clin Psychiatry 2005;66(1):135-136

Robert J. Teunisse, PhD

Letter to the Editor

Reply to Problems in Assessing Musical Hallucination

J Clin Psychiatry 2005;66(1):136-136

Abraham Weizman, MD; Shai Konas, MD; Haggai Hermesh, MD; Roni Shiloh, MD; Reuven Dar, PhD; Sofi Marom, PhD; Ruth Gross-Isseroff, DSc

Letter to the Editor

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

J Clin Psychiatry 2005;66(1):137-137

James L. Karagianis, MD, FRCPC; Eduardo Dunayevich, MD

Letter to the Editor

Reply to "Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics."

J Clin Psychiatry 2005;66(1):138

Natalie Alméras, PhD; Jean-Pierre Després, PhD, FAHA; Julie Villeneuve, BPharm; Roch-Hugo Bouchard, MD; Marie-Franch Demers, BPharm

Book Review

What Every Patient, Family, Friend, and Caregiver Needs to Know About Psychiatry, 2nd ed

J Clin Psychiatry 2005;66(1):139-139

Page Burkholder, MD

Book Review

Becoming a Therapist: What Do I Say, and Why?

J Clin Psychiatry 2005;66(1):139-139

Rita Hargrave

Volume 66 • 2005 • 1

Brainstorms

Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder?

Original Research

Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity

The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation

Sertraline Treatment of Pathological Gambling: A Pilot Study

Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients

Assessing the Utility of Atypical Antipsychotic Medication in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders

A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine: Efficacy and Safety

Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety Disorder: A Double-Blind, Prospective Comparison Between Paroxetine and Sertraline

Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

Academic Highlights

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

Letter to the Editor

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

Interactions of Cyclobenzaprine and Tricyclic Antidepressants

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

Problems in Assessing Musical Hallucinations

Reply to Problems in Assessing Musical Hallucination

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

Reply to "Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics."

Book Review

What Every Patient, Family, Friend, and Caregiver Needs to Know About Psychiatry, 2nd ed

Becoming a Therapist: What Do I Say, and Why?

ELSEWHERE:

FOLLOW US:

Volume 66 • 2005 • 1

Brainstorms

Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder?

Original Research

Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity

The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation

Sertraline Treatment of Pathological Gambling: A Pilot Study

Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients

Assessing the Utility of Atypical Antipsychotic Medication in Adults With Mild Mental Retardation and Comorbid Psychiatric Disorders

A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine: Efficacy and Safety

Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety Disorder: A Double-Blind, Prospective Comparison Between Paroxetine and Sertraline

Incidence of Sexual Side Effects in Refractory Depression During Treatment With Citalopram or Paroxetine

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

Academic Highlights

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

Letter to the Editor

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

Interactions of Cyclobenzaprine and Tricyclic Antidepressants

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

Problems in Assessing Musical Hallucinations

Reply to Problems in Assessing Musical Hallucination

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

Reply to "Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics."

Book Review

What Every Patient, Family, Friend, and Caregiver Needs to Know About Psychiatry, 2nd ed

Becoming a Therapist: What Do I Say, and Why?

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles